New drug found to safely reduce amyloid beta production in people with Alzheimer’s disease
New research published today in Science Translational Medicine presents results from a drug trial that explores reducing the production of amyloid as a way of treating Alzheimer’s disease. This study, carried out at Merck Research Laboratories in New Jersey, USA, describes early tests of a new drug, (full name BACE1 inhibitor verubecestat (MK-8931)) found to…
